Department of Translational Genomics
About the Department
Under the leadership of John Carpten, PhD, director of the Institute of Translational Genomics and chair of the Department of Translational Genomics, collaborative effort intends to redefine and further precision medicine. Carpten is an award-winning genomic scientist who is renowned for his key discoveries and contributions in the fields of cancer genetics and genomics.
“USC allows future Translational Genomics faculty and me to bring translational components directly into the clinical enterprise,” Carpten says. “Not only is the department situated in a distinguished medical school, but it also physically operates within the confines of a hospital. My department will have access to patients who are coming right through the Keck Medicine of USC clinical system. Our ultimate goal is to bring to bear novel technologies and molecular insights to help improve outcomes for our patients.”
The future of medicine is personalizedJohn Carpten joins the Keck School of Medicine to connect the dots between individual cancer patients and the best treatments The technological advances that have allowed doctors to differentiate tumors based on their distinct genetic make-up are part of a revolution in medicine that is known as personalized or precision medicine. Where treating cancer was